Med Chem of Antidiabetics Flashcards

1
Q

Human Insulin

A
  • 51 amino acids
  • A and B chain linked by two disulfide bonds
  • Additional disulfide bond within the A chain
  • Degrades by insulinase that cleaves disulfides
  • T1/2 = ~5-10 minutes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hexamer-Monomer Conversion

A
  • Stored as a hexamer
  • Active form is a monomer
  • Hexamer is inactive but stable long-term
  • The conversion from hexamer to monomer is cenral to insulin formulations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Factors Increasing Hexamers

A
  • Zinc ions
  • High insulin formations
  • Hexamers are too large to permeate capillary walls
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Aggregation Equilibrium Shifting

A
  • Point mutations
  • Chemical Modifications
  • Utilizes these methods in fast or slow acting insulin formulations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hexamer Modifications

A
  • Proline 28 that normally interacts between B chains in dimer forms is replaces
  • Fast-acting insulin lispro: proline B28 is replaces by lysine, destabilizes the two monomers
  • Fast-acting insulin aspart: proline B28 is replaces by aspartic acid which also disturbs the reaction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Insulin Analog

A
  • Altered insulin
  • Utilize genetic engineering (aka recombinant DNA technology) to alter amino acid sequences and therefore alter ADME characteristics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Types of Insulin Analogs

A
  • Faster acing: more readily absorbed from injection site and intended to supply prandial insulin needs
  • Slow Insulin: releases over a period of 8-24 hours to supply basal insulin needs
  • Rapid acting: substitute aa at beginning or end of B chain, peak fast and short durations
  • Long-acting: form depot reservoirs upon administration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Long-Acting Insulin Examples

A
  • Glargine: replace A21 Asn by Gly and add two Args to C-terminus of the B chain
  • Detemir: removing B30 Thr and adding a C14 fatty acid to the B29 Lys
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Insulin Lispro

A
  • Humalog
  • Lysine and proline exchanged at B28 and B29
  • Equilibrium shifts away from hexamer formation
  • Increases rate of monomer formation and therefore the rate of absorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Insulin Aspart

A
  • Novolog
  • Aspartate substitutued for proline at B28
  • Shifts equilibrium away from hexamer formation
  • Increasing rate of absorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Fiasp

A
  • Fast-acting insulin aspart
  • Flexibility in administration time for meals due to faster onset and offset
  • Niacinamide (vitamin B3) used to increase its absorption from SC tissue
  • Arginine is added to enhance its stability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Insulin Glulisine

A
  • Apidra
  • Lysine is substituted for asparagine at B3 and glutamate for lysine at B29
  • Short-acting nature is related to insulin stabilizer used in formation that takes the place of zinc
  • Hexamer is never formed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Insulin Glargine

A
  • Lantus
  • Long-acting insulin by adding two arginines to C-terminus
  • Shifts isoelectric point from 5.4 to 6.7
  • Slowly dissolves into bloodstream over 24 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Isoelectric point

A
  • pH when protein net charge is zero
  • Lowest solubility
  • Once determined, back off by one or two pH units to attain solubility and avoid protein aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Insulin Detemir

A
  • Acylated derivative
  • Binds to albumin through a fatty-acid chain attached to lysin at B29
  • Reduces free detemir levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Insulin Degludec

A
  • Tresiba
  • des-B30 human insulin that is fatty-acylated at Lys B29
  • Stable di-hexameric structure created
  • Persists for up to 42 hours
17
Q

NPH

A
  • Intermediate-acting
  • Combined with regular insulin with protamine (positively charged polypeptide
  • Limited solubility of this insulin in SC fluids leads to intermediate action
18
Q

Oral Hypoglycemia Agents

A
  • Insulin secretagogue - amplify insulin secretion
  • Insulin sensitizer
  • Biguanide
19
Q

Sulfonylureas

A
  • Modified structure of sulfonamide
  • Contain central phenylsulfonylurea
  • Many R1 substituents are active, the larger additions enhance activities of 2nd generation sulfonylureas
  • R2 need to be reasonably bulky and lipophilic
20
Q

Thiazolidinedione

A
  • Need R to be para to phenyl ring attache dto central nucleus for agonist activity
  • Attached via methylene bridge
  • Negatively charged conjugate base mimics caboxylate anion of the natural fatty acid ligands (binds to PPAR-gamma)
21
Q

Biguanide

A
  • Two guanidine groups with different side chains
  • Reduce sugar absorption form GI tract, reduce gluconeogenesis, increase muscle and fat cell uptake of glucose
  • Exists almost exclusively as protonated, charged species in body
  • First-line for T2DM
22
Q

GLP-1 RA

A
  • GLP-1 is a 30-31 aa peptide made by L cells in GI tract
  • Agonists remove His-Ala from N-terminus (Byetta)
  • Exenatide (Byetta) agonizes these receptors